Company
About InCarda
Our Team
Board of Directors
Investors
Scientific and Medical Advisors
Our Pipeline
Pipeline Overview
InRhythm™ – Inhaled Antiarrhythmic for PAF
About Atrial Fibrillation
News
Contact
Company
About InCarda
Our Team
Board of Directors
Investors
Scientific and Medical Advisors
Our Pipeline
Pipeline Overview
InRhythm™ – Inhaled Antiarrhythmic for PAF
About Atrial Fibrillation
News
Contact
January 1, 2018
In
Videos
Patients React to InRhythm™
We’re proud to share what’s new.
Sign up to be the first to learn about new developments.
Name
*
:
Email
*
:
Company
*
:
We respect your
email privacy
Tweets by InCardaThera
Back to News & Updates
X
InCarda Therapeutics Recruiting for Phase 2 Clinical Trial in PAF
Learn More
